Jangzhuo Qinggan prescription and irbesartan in the treatment of essential hypertension(Hepatogastric Damp-heat), randomized, parallel-controlled, multi-center clinical study.
Charged by the five research centers in line with traditional Chinese medicine hepatogastric Damp-heat syndrome 240 cases have hypertension, and overweight, as well as blood lipid disorders or diabetes were randomly divided into Chinese herbal compound Jiangzhuo Qinggan prescription group and western medicine irbesartan group.The treatment groups were compared 4-week step-down and regulation of blood lipids, blood sugar effect.
Study Type
OBSERVATIONAL
Enrollment
240
Beijing Medical University ,Dongzhimen Hospital
Beijing, Beijing Municipality, China
Beijing Medical University,Dongfang Hospital
Beijing, Beijing Municipality, China
China Academy of Chinese Medical Sciences,Guang'anmen Hospital
Beijing, Beijing Municipality, China
Chinese Academy of Medical Sciences Fu Wai Cardiovascular Hospital
Beijing, Beijing Municipality, China
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Capital University of Medical, Anzhen Hospital
Beijng, Beijing Municipality, China